IR@PKUHSC  > 北京大学第一临床医学院  > 心血管内科
学科主题临床医学
E112D polymorphism in the prolylcarboxypeptidase gene is associated with blood pressure response to benazepril in Chinese hypertensive patients
Zhang Yan2; Hong Xiu-mei1; Xing Hou-xun1; Li Jian-ping2; Huo Yong2; Xu Xi-ping1
关键词Benazepril Prolylcarboxypeptidase Polymorphism Hypertension
刊名CHINESE MEDICAL JOURNAL
2009-10-20
DOI10.3760/cma.j.issn.0366-6999.2009.20.012
122期:20页:2461-2465
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Medicine, General & Internal
研究领域[WOS]General & Internal Medicine
关键词[WOS]ANGIOTENSINOGEN GENE ; PLASMA PREKALLIKREIN ; ENZYME ; RECEPTOR ; ACTIVATION ; THERAPY ; CELLS ; RISK
英文摘要

Background Marked interindividual variation exists in blood pressure response to benazepril, which is considered to have genetic basis. Our objectives were to evaluate whether the E112D polymorphism in the prolylcarboxypeptidase (PRCP) gene has impact on blood pressure response to benazepril.

Methods Hypertensive patients from Huoqiu County and Yuexi County of Anhui Province received daily treatment with an oral dosage of 10 mg benazepril for 15 days. Genotypes of the E112D polymorphism in the PRCP gene were determined by TaqMan SNP genotyping assay. Multivariate linear and Logistic regressions using generalized estimating equation model were performed in a total of 1092 patients to evaluate the association of PRCP genotypes and blood pressure response to benazepril.

Results Patients carrying ED or DD genotype had a less systolic blood pressure reduction (adjusted beta= -3.7+/-1.1, P <0.001), a less diastolic blood pressure reduction (adjusted beta= -3.1+/-0.8, P <0.001) and a lower percentage of reaching target blood pressure defined as SBP lower than 140 mmHg and DBP lower than 90 mmHg (adjusted OR=0.6, P=0.005) than those patients carrying EE genotype. In addition, the results from stratified analysis by county (Huoqiu or Yuexi) were similar to those observed in the pooled population.

Conclusions Our data suggest that the E112D polymorphism in the PRCP gene may be a useful genetic marker to predict the anti hypertensive effect of short-term benazepril treatment in hypertensive patients of Anhui Province, China. Chin Med J 2009;122(20):2461-2465

语种英语
WOS记录号WOS:000271367000012
引用统计
被引频次:16[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/55670
专题北京大学第一临床医学院_心血管内科
作者单位1.Anhui Med Univ, Inst Biomed, Hefei 230032, Anhui, Peoples R China
2.Peking Univ, Hosp 1, Dept Cardiol, Beijing 100034, Peoples R China
推荐引用方式
GB/T 7714
Zhang Yan,Hong Xiu-mei,Xing Hou-xun,et al. E112D polymorphism in the prolylcarboxypeptidase gene is associated with blood pressure response to benazepril in Chinese hypertensive patients[J]. CHINESE MEDICAL JOURNAL,2009,122(20):2461-2465.
APA Zhang Yan,Hong Xiu-mei,Xing Hou-xun,Li Jian-ping,Huo Yong,&Xu Xi-ping.(2009).E112D polymorphism in the prolylcarboxypeptidase gene is associated with blood pressure response to benazepril in Chinese hypertensive patients.CHINESE MEDICAL JOURNAL,122(20),2461-2465.
MLA Zhang Yan,et al."E112D polymorphism in the prolylcarboxypeptidase gene is associated with blood pressure response to benazepril in Chinese hypertensive patients".CHINESE MEDICAL JOURNAL 122.20(2009):2461-2465.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Zhang Yan]的文章
[Hong Xiu-mei]的文章
[Xing Hou-xun]的文章
百度学术
百度学术中相似的文章
[Zhang Yan]的文章
[Hong Xiu-mei]的文章
[Xing Hou-xun]的文章
必应学术
必应学术中相似的文章
[Zhang Yan]的文章
[Hong Xiu-mei]的文章
[Xing Hou-xun]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。